A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

Rampotas A, Aspa-Cilleruelo JM, Koster L, Avenoso D, Passweg J, Sala E, Robin M, Myhre AE, de Witte M, Nur E, Chevallier P, Schroeder T, Srour M, Chiusolo P, Salmenniemi U, Verbeek M, Finazzi MC, Castilla-Llorente C, Rubio MT, Sobieralski P, Sockel K, Alabdulkarim A, Drozd-Sokolowska J, Raj K, Battipaglia G, Czerw T, Polverelli N, Hernández-Boluda JC, McLornan DP

Open source

DOI
10.1038/s41409-025-02780-2
Published
2026 Mar
Container
Bone marrow transplantation
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41409-025-02780-2,
  title = {A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.},
  author = {Rampotas A and Aspa-Cilleruelo JM and Koster L and Avenoso D and Passweg J and Sala E and Robin M and Myhre AE and de Witte M and Nur E and Chevallier P and Schroeder T and Srour M and Chiusolo P and Salmenniemi U and Verbeek M and Finazzi MC and Castilla-Llorente C and Rubio MT and Sobieralski P and Sockel K and Alabdulkarim A and Drozd-Sokolowska J and Raj K and Battipaglia G and Czerw T and Polverelli N and Hernández-Boluda JC and McLornan DP},
  year = {2026},
  journal = {Bone marrow transplantation},
  doi = {10.1038/s41409-025-02780-2},
  url = {https://doi.org/10.1038/s41409-025-02780-2}
}

RIS

TY  - JOUR
TI  - A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.
AU  - Rampotas A
AU  - Aspa-Cilleruelo JM
AU  - Koster L
AU  - Avenoso D
AU  - Passweg J
AU  - Sala E
AU  - Robin M
AU  - Myhre AE
AU  - de Witte M
AU  - Nur E
AU  - Chevallier P
AU  - Schroeder T
AU  - Srour M
AU  - Chiusolo P
AU  - Salmenniemi U
AU  - Verbeek M
AU  - Finazzi MC
AU  - Castilla-Llorente C
AU  - Rubio MT
AU  - Sobieralski P
AU  - Sockel K
AU  - Alabdulkarim A
AU  - Drozd-Sokolowska J
AU  - Raj K
AU  - Battipaglia G
AU  - Czerw T
AU  - Polverelli N
AU  - Hernández-Boluda JC
AU  - McLornan DP
PY  - 2026
JO  - Bone marrow transplantation
DO  - 10.1038/s41409-025-02780-2
UR  - https://doi.org/10.1038/s41409-025-02780-2
ER  - 

APA

A, R., JM, A., L, K., D, A., J, P., E, S., M, R., AE, M., M, D. W., E, N., P, C., T, S., M, S., P, C., U, S., M, V., MC, F., C, C., MT, R., P, S., K, S., A, A., J, D., K, R., G, B., T, C., N, P., JC, H., & DP, M. (2026). A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.. Bone marrow transplantation. https://doi.org/10.1038/s41409-025-02780-2

Source records